Question 1

What are the specific benefits of the Triple Antithrombotic Therapy compared to the standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my eligibility be determined based on my current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the medications involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic or have follow-up calls during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience any unusual symptoms while participating in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan for heart health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI clinical trial (NCT05638867). Contact the study team or your healthcare provider for specific answers.

What this study is about